Filing Details
- Accession Number:
- 0001138723-10-000044
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-06-11 13:00:00
- Reporting Period:
- 2010-06-09
- Filing Date:
- 2010-06-11
- Accepted Time:
- 2010-06-11 17:54:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1138723 | Accuray Inc | ARAY | Surgical & Medical Instruments & Apparatus (3841) | 770268932 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1387516 | Euan Thomson | 1310 Chesapeake Terrace Sunnyvale CA 94089 | President & Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-06-09 | 12,500 | $0.75 | 57,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-06-09 | 12,500 | $6.38 | 45,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2010-06-09 | 10,000 | $0.75 | 55,000 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2010-06-09 | 12,500 | $0.00 | 12,500 | $0.75 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2010-06-09 | 10,000 | $0.00 | 10,000 | $0.75 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 295,832 | 2012-03-28 | No | 4 | M | Direct | |
| 285,832 | 2012-03-28 | No | 4 | M | Direct |
Footnotes
- A portion of these options are being sold so that a portion of the proceeds may be used to increase the CEO's ownership of Accuray stock in anticipation of the adoption of stock ownership guidelines for management by the Board of Directors of Accuray Incorporated in fiscal year 2011.
- A total of 12,500 shares were sold pursuant to a 10b-5-1 Plan at an average sale price of $6.3795 per share. The actual sale price for the shares was: 700 shares at $6.31; 600 shares at $6.32; 700 shares at $6.33; 100 shares at $6.3350; 300 shares at $6.34; 1700 shares at $6.35; 100 shares at $6.3550; 2101 shares at $6.36; 100 shares at $6.3650; 899 shares at $6.37; 400 shares at $6.375; 598 shares at $6.38; 2 shares at $6.39; 600 shares at $6.40; 100 shares at $6.4050; 600 shares at $6.41; 591 shares at $6.42; 209 shares at $6.43; 300 shares at $6.44; 551 shares at $6.45; 200 shares at $6.46; 549 shares at $6.47; 500 shares at $6.48.
- The options are exercisable as they vest. A total of 25% of the entire number of shares subject to this stock option becomes vested and fully exercisable on the first anniversary of the vesting commencement date and the remaining shares subject to this stock option vest and become exercisable in equal monthly installments, ratably over the following 36 months.
Billionaire Hedge Funds
